BriaCell Therapeutics Corp. (8BT)
FSX
3.22
-0.02 (-0.62%)
Real-time Data
06:00 AM
Day's Range
3.223.22
52 wk Range
2.2211.90
Financial Statements - 8BT - BriaCell Therapeutics Corp.
Revenue
0
Net Income
-4.23M▲ 79.1%
EBITDA
-28.41M▼ 12.2%
Free Cash Flow
-21.12M▲ 11.0%
Income Statement
| Period Ending | 2024-07-31 | 2023-07-31 | 2022-07-31 | 2021-07-31 | 2020-07-31 | 2019-07-31 |
|---|---|---|---|---|---|---|
| Sales | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Goods | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | -28.64M | -23.27M | -15.28M | -6.97M | -2.75M | -3.55M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | 24.15M | 2.07M | -11.68M | -6.76M | -55.41K | 258.38K |
| Pre Tax Income | -4.23M | -20.30M | -26.83M | -13.81M | -2.82M | -3.30M |
| Income Tax | - | - | - | - | - | - |
| Net Income | -4.23M | -20.30M | -26.83M | -13.81M | -2.82M | -3.30M |
| EPS Basic | -43.68 | -1.3 | -1.73 | -0.09 | -5.64 | -8.13 |
| EPS Diluted | -43.68 | -1.3 | -1.73 | -0.09 | -5.64 | -8.13 |
| Basic Shares Outstanding | 94.27K | 16.25M | 16.12M | 4.70M | 742.95K | 603.26K |
| Diluted Shares Outstanding | 94.27K | 16.25M | 16.12M | 4.70M | 742.95K | 603.26K |
| Ebit | -4.23M | -23.27M | -26.83M | -13.73M | -2.80M | -3.29M |
| Ebitda | -28.41M | -25.33M | -15.13M | -6.95M | -2.78M | -3.29M |
| Net Income Continuous Operations | -4.23M | -20.30M | -26.83M | -13.81M | -2.82M | -3.30M |
| Minority Interests | 140.08K | 0 | - | - | - | - |
| Preferred Stock Dividends | - | - | - | - | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
